Idiopathic Pulmonary Fibrosis Market Poised to Reach US$ 6,736.49 Million by 2035 as Late-Stage Pipelines and Novel Mechanisms Transform Treatment Outcomes | Astute Analytica
Idiopathic pulmonary fibrosis represents a high need specialty market, with global IPF drug sales of roughly…